Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableStudy completedNCT00083733
What this trial is testing

Genetic and Protein Profiling in Normal and Cancerous Breast Tissue

Who this might be right for
Breast Neoplasms
National Cancer Institute (NCI) 216
Large-scale testing (Phase 3)Study completedNCT04799249
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

Who this might be right for
TNBC - Triple-Negative Breast CancerBreast Cancer
G1 Therapeutics, Inc. 194
Large-scale testing (Phase 3)Active Not RecruitingNCT04711252
What this trial is testing

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 1,370
Not applicableStudy completedNCT02583828
What this trial is testing

Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
Capital Medical University 200
Testing effectiveness (Phase 2)Study completedNCT01835236
What this trial is testing

Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

Who this might be right for
Metastatic Breast Cancer
Swiss Cancer Institute 208
Early research (Phase 1)Study completedNCT00707707
What this trial is testing

Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast CancerMetastatic Breast Cancer
AstraZeneca 19
Large-scale testing (Phase 3)Study completedNCT00096967
What this trial is testing

Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Who this might be right for
Breast CancerColorectal CancerMetastases
Genentech, Inc. 100
Not applicableUnknownNCT06015100
What this trial is testing

Efficacy and Safety of Inetetamab Plus Pyrotiniband and Capecitabine in HER2-positive Metastatic Breast Cancer Patients With or Without Brain Metastasis

Who this might be right for
Breast Cancer
Yan Xue 40
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Testing effectiveness (Phase 2)Active Not RecruitingNCT04829604
What this trial is testing

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

Who this might be right for
HER2 Positive Metastatic Breast Cancer
Ambrx, Inc. 72
Early research (Phase 1)Study completedNCT02206334
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
Male Breast CarcinomaProstate AdenocarcinomaRecurrent Breast Carcinoma+5 more
NRG Oncology 42
Testing effectiveness (Phase 2)Study completedNCT00821964
What this trial is testing

Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerSkin Metastases+1 more
University of Washington 15
Not applicableStudy completedNCT01053104
What this trial is testing

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Who this might be right for
Metastatic Colorectal CancerMetastatic Breast Cancer
University of Oxford 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07492121
What this trial is testing

Screening for Brain Metastases

Who this might be right for
Lung Cancer Stage IVMelanoma Stage IVBreast Cancer Metastatic
University of Zurich 180
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Large-scale testing (Phase 3)UnknownNCT01782274
What this trial is testing

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Who this might be right for
Neoplasm Metastasis
NeuroVita Clinic 60
Testing effectiveness (Phase 2)Study completedNCT00899574
What this trial is testing

Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases

Who this might be right for
Breast CancerBreast Neoplasms
NYU Langone Health 10
Testing effectiveness (Phase 2)Study completedNCT01038804
What this trial is testing

YM155 Plus Docetaxel as First-Line Treatment in Subjects With HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Astellas Pharma Inc 101
Testing effectiveness (Phase 2)Looking for participantsNCT04802759
What this trial is testing

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Who this might be right for
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
Hoffmann-La Roche 316
Next Page